Hemab Therapeutics Holdings, Inc. (COAG)
41.45
+1.03
(+2.55%)
USD |
NASDAQ |
Oct 30, 16:00
41.45
0.00 (0.00%)
After-Hours: 20:00
Hemab Therapeutics Holdings Market Cap : 1.936B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.936B |
| October 29, 2026 | 1.888B |
| October 28, 2026 | 1.798B |
| October 27, 2026 | 1.793B |
| October 26, 2026 | 1.682B |
| October 23, 2026 | 1.607B |
| October 22, 2026 | 1.626B |
| October 21, 2026 | 1.651B |
| October 20, 2026 | 1.596B |
| October 19, 2026 | 1.499B |
| October 16, 2026 | 1.404B |
| October 15, 2026 | 1.519B |
| October 14, 2026 | 1.398B |
| October 13, 2026 | 1.392B |
| October 12, 2026 | 1.419B |
| October 09, 2026 | 1.477B |
| October 08, 2026 | 1.443B |
| October 07, 2026 | 1.340B |
| October 06, 2026 | 1.325B |
| October 05, 2026 | 1.429B |
| October 02, 2026 | 1.453B |
| October 01, 2026 | 1.451B |
| September 30, 2026 | 1.440B |
| September 29, 2026 | 1.523B |
| September 28, 2026 | 1.547B |
| Date | Value |
|---|---|
| September 25, 2026 | 1.623B |
| September 24, 2026 | 1.668B |
| September 23, 2026 | 1.715B |
| September 22, 2026 | 1.786B |
| September 21, 2026 | 1.773B |
| September 18, 2026 | 1.924B |
| September 17, 2026 | 1.925B |
| September 16, 2026 | 1.914B |
| September 15, 2026 | 1.873B |
| September 14, 2026 | 1.890B |
| September 11, 2026 | 1.840B |
| September 10, 2026 | 1.863B |
| September 09, 2026 | 2.078B |
| September 08, 2026 | 2.082B |
| September 04, 2026 | 2.074B |
| September 03, 2026 | 2.072B |
| September 02, 2026 | 2.088B |
| September 01, 2026 | 2.056B |
| August 31, 2026 | 2.136B |
| August 28, 2026 | 2.094B |
| August 27, 2026 | 2.311B |
| August 26, 2026 | 2.297B |
| August 25, 2026 | 2.319B |
| August 24, 2026 | 2.180B |
| August 21, 2026 | 2.296B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.454B |
| Oncolytics Biotech, Inc. | 53.02M |
| Sangamo Therapeutics, Inc. | 48.06M |
| Sarepta Therapeutics, Inc. | 1.967B |
| Anixa Biosciences, Inc. | 107.90M |
Market Cap Related Metrics
| Price to Book Value | 4.262 |
| Price | 41.45 |
| Earnings Yield | -3.84% |